[at-l] FantasyLand <OFF TOPIC> {Was: Did Any of You See This?---}

[thornel at attglobal.net (W F Thorneloe)]

I salute your genius, investigation and prose!

If only it had something to do with the AT and/or reality.

Have you shown that there were _no_ clinical trials prior to approval of 
that agent.  Have you shown that this was a failure of your government with 
checks and balances, even among agencies of the Executive Branch? It is 
really not uncommon nor a scandal that adverse events result in drug 
withdrawal and restrictions after marketing. There is a major difference in 
a premarket, Phase III, study with a few hundred carefully selected 
patients and real world thousands and millions of patients in the first 
couple of years. That event resulted in several efforts to slow down 
product approval and increase placebo control studies.

If you wanted to cite some current history, Serzone might have been a 
better argument. You might have even discussed FDA's very recent efforts to 
force pharmaceutical companies to publicize unfavorable studies, such as 
the lack of studies showing benefit of Paxil in depressed adolescents. 
Rhabdomyalysis from some statins has been a problem, with Baycor a great 
example of post-marketing problems.

Go take some Dammital and calm down.

OrangeBug

<Didn't Tambocor occur during Bush I?>

At 05:12 PM 7/17/2004 -0400, J Bryan Kramer wrote:
>Sorry I wasn't able to satisfy you instantly with the book title and drug
>name, I read hundreds of books a year and they tend to blur together. A
>problem I know you don't have since its so hard to insert a book up your
>anal cavity where your head is.